Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Veracyte (VCYT) Invested Capital: 2012-2025

Historic Invested Capital for Veracyte (VCYT) over the last 13 years, with Sep 2025 value amounting to $1.3 billion.

  • Veracyte's Invested Capital rose 7.42% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 7.42%. This contributed to the annual value of $1.2 billion for FY2024, which is 13.97% up from last year.
  • Veracyte's Invested Capital amounted to $1.3 billion in Q3 2025, which was up 2.98% from $1.2 billion recorded in Q2 2025.
  • Veracyte's 5-year Invested Capital high stood at $1.3 billion for Q3 2025, and its period low was $972.1 million during Q2 2021.
  • In the last 3 years, Veracyte's Invested Capital had a median value of $1.1 billion in 2024 and averaged $1.1 billion.
  • As far as peak fluctuations go, Veracyte's Invested Capital spiked by 328.33% in 2021, and later dropped by 5.30% in 2022.
  • Quarterly analysis of 5 years shows Veracyte's Invested Capital stood at $1.1 billion in 2021, then decreased by 1.39% to $1.1 billion in 2022, then decreased by 3.19% to $1.0 billion in 2023, then grew by 13.97% to $1.2 billion in 2024, then climbed by 7.42% to $1.3 billion in 2025.
  • Its Invested Capital stands at $1.3 billion for Q3 2025, versus $1.2 billion for Q2 2025 and $1.2 billion for Q1 2025.